share

Verdinexor (Kpt-335) CAS NO 1392136-43-4


Unit Price:

CAS No.:1392136-43-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Verdinexor (KPT-335) is a potent, orally bioavailable, and selective inhibitor of the nuclear export protein Exportin 1 (XPO1/CRM1). This small molecule compound is a critical research tool and a promising therapeutic candidate for its role in forcing the nuclear retention and activation of tumor suppressor proteins. It is primarily utilized by pharmaceutical R&D teams, academic researchers, and biotechnology companies focused on oncology, virology, and autoimmune disease research.

Application

  • Oncology Research: Investigated as a therapeutic agent in preclinical and clinical studies for various cancers, including hematological malignancies (e.g., AML, lymphoma) and solid tumors.
  • Antiviral Research: Studied for its potential to inhibit the replication of viruses, such as influenza and HIV, by blocking the nuclear export of viral components.
  • Autoimmune & Inflammatory Disease Models: Used in research to modulate immune responses by affecting the nuclear export of key inflammatory transcription factors.
  • Mechanistic Biology Studies: A key pharmacological tool for studying XPO1-mediated nuclear export pathways and cellular signaling in disease models.
  • Drug Combination Studies: Employed in research to evaluate synergistic effects with other chemotherapeutic or targeted agents.
  • Biomarker Discovery: Used in research to identify and validate biomarkers associated with XPO1 inhibition and treatment response.

Basic Information

Product Name Verdinexor (KPT-335)
CAS No. 1392136-43-4
Molecular Formula C₁₇H₁₁F₃N₄O₂
Molecular Weight 360.29 g/mol
Synonyms KPT-335; Verdinexor; Selinexor analog; (Z)-3-((3,5-Bis(trifluoromethyl)phenyl)amino)-N'-(2-methyl-1H-indol-5-yl)-2-(pyridin-4-yl)acrylohydrazide; CRM1 Inhibitor KPT-335; XPO1 Inhibitor KPT-335; Selective Inhibitor of Nuclear Export (SINE) compound
EINECS Contact for details

Quality Control

Our Verdinexor (KPT-335) is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and residual solvent analysis. We provide a detailed Certificate of Analysis (COA) with every shipment to ensure traceability and compliance with your research-grade specifications.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below under an inert atmosphere. The compound is hygroscopic (moisture-sensitive); allow the sealed vial to equilibrate to room temperature before opening to minimize moisture absorption.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Retention time corresponds to reference standard
Identification (MS) Consistent with molecular weight
Purity (HPLC) ≥98.0%
Water Content (KF) ≤1.0%
Residual Solvents (GC) Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.